WEREWOLF THERAPEUTICS, INC. Public Float
WEREWOLF THERAPEUTICS, INC. (HOWL) had Public Float of $39.56 million as of 2025-06-30, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $39.56M.
- 2024-06-28: Entity Public Float $69.69M.
- 2023-06-30: Entity Public Float $67.36M.
- 2022-06-30: Entity Public Float $59.29M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $39.56M 10-K · filed 2026-03-27 |
| 2024-06-28 | $69.69M 10-K · filed 2025-03-11 |
| 2023-06-30 | $67.36M 10-K · filed 2024-03-07 |
| 2022-06-30 | $59.29M 10-K · filed 2023-03-23 |
| 2021-06-30 | $201.87M 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |